Filtered By:
Condition: Anaphylactic Shock
Management: Centers for Disease Control and Prevention (CDC)
This page shows you your search results in order of date.
Order by Relevance | Date
Total 12 results found since Jan 2013.
Outcomes of allergic-type reactions after messenger RNA coronavirus disease 2019 vaccination at 3 military medical centers
In response to the global coronavirus disease 2019 (COVID-19) pandemic, 2 messenger RNA (mRNA) COVID-19 vaccines were developed and authorized for use.1,2 Adverse events following immunization (AEFI) have occurred after receipt of these vaccines to include anaphylaxis that is estimated to occur at a rate of 2.5 to 11 cases per 1 million doses.3 Several studies have found tolerance to vaccine challenge in these individuals, suggesting the reactions are likely not immunoglobulin (Ig)E driven.4,5 The Centers for Disease Control and Prevention now considers nonsevere, immediate, allergic-type reactions after a dose of a COVID-...
Source: Annals of Allergy, Asthma and Immunology - May 19, 2022 Category: Allergy & Immunology Authors: Benjamin D. St. Clair, Donna L. Hoffman, Bruce McClenathan, Taylor Banks, Rachel U. Lee Tags: Letters Source Type: research
Outcomes of Allergic Type Reactions Following mRNA COVID-19 Vaccination at Three Military Medical Centers
In response to the global COVID-19 pandemic two mRNA COVID-19 vaccines were developed and authorized for use1,2. Adverse events following immunization (AEFI) have occurred following receipt of these vaccines to include anaphylaxis that is estimated to occur at a rate of 2.5 to 11 cases per 1 million doses3. Several studies have demonstrated tolerance to vaccine challenge in these individuals, suggesting the reactions are likely not IgE driven4,5. The Centers for Disease Control and Prevention now considers non-severe, immediate allergic-type reactions following a dose of a COVID-19 vaccine a precaution, not a contraindicat...
Source: Annals of Allergy, Asthma and Immunology - May 19, 2022 Category: Allergy & Immunology Authors: Benjamin D. St Clair, Donna L. Hoffman, Bruce McClenathan, Taylor Banks, Rachel U. Lee Tags: Letters Source Type: research
Rapid progress in our understanding of COVID-19 vaccine allergy: A cause for optimism, not hesitancy
Anaphylaxis is a life-threatening condition and when associated with vaccination, leads to vaccine hesitancy. The concerns around vaccine-related anaphylaxis have become even more important during the coronavirus disease 2019 (COVID-19) pandemic where the COVID-19 vaccines remain one of our most important tools. Although rates of anaphylaxis to COVID-19 vaccines are not significantly different from those to other vaccines, Centers for Disease Control and Prevention guidance recommends avoidance of the same COVID-19 vaccine in individuals who had an allergic reaction or are allergic to a COVID-19 vaccine component.
Source: Journal of Allergy and Clinical Immunology - April 7, 2022 Category: Allergy & Immunology Authors: Aleena Banerji, Allison E. Norton, Kimberly G. Blumenthal, Cosby A. Stone, Elizabeth Phillips Tags: Rostra Source Type: research
Disproportionality analysis of anaphylactic reactions after vaccination with messenger RNA coronavirus disease 2019 vaccines in the United States
One year after the emergence of the novel severe acute respiratory syndrome coronavirus 2 that causes the coronavirus disease 2019 (COVID-19), the US Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for 2 novel messenger RNA (mRNA) COVID-19 vaccines. Reports of acute hypersensitivity reactions in the real world after EUA are creating anxiety among potential vaccine recipients and may delay achieving universal vaccination.1 Although the Centers for Disease Control and Prevention (CDC) and the FDA jointly monitor vaccine adverse reactions through a variety of surveillance systems, such as the Vacc...
Source: Annals of Allergy, Asthma and Immunology - April 7, 2021 Category: Allergy & Immunology Authors: Guillermo Rodriguez-Nava, Goar Egoryan, Daniela Patricia Trelles-Garcia, Maria Adriana Yanez-Bello, Ricardo Murguia-Fuentes Tags: Letter Source Type: research
Disproportionality Analysis of Anaphylactic Reactions after Vaccination with mRNA COVID-19 Vaccines in the United States
One year after the emergence of the novel coronavirus SARS-CoV-2 that causes the coronavirus disease 2019 (COVID-19), the United States Food and Drug Administration (FDA) granted two Emergency Use Authorizations (EUA) for two novel mRNA COVID-19 vaccines. Reports of acute hypersensitivity reactions in the real world after EUA are creating anxiety among potential vaccine recipients and may delay achieving universal vaccination (1). Although the Centers for Disease Control and Prevention (CDC) and the FDA jointly monitor vaccine adverse reactions through a variety of surveillance systems such as the Vaccine Adverse Event Rep...
Source: Annals of Allergy, Asthma and Immunology - April 7, 2021 Category: Allergy & Immunology Authors: Guillermo Rodriguez-Nava, Goar Egoryan, Daniela Patricia Trelles-Garcia, Maria Adriana Yanez-Bello, Ricardo Murguia-Fuentes Tags: Letter Source Type: research
Too Many Americans Still Mistrust the COVID-19 Vaccines. Here ’s Why
If you’re feeling impatient waiting your turn for a COVID-19 vaccine, here’s a little good news: Angela Padgett will gladly give you her place in line—at least for now. Padgett, president of a day spa in Raleigh, N.C., is under no illusions about the mortal danger the pandemic poses to herself, her family and the world writ large—indeed, she had COVID-19 back in July. But as for the vaccine that is supposed to put an end to all of the suffering at last? Not today.
“I am a little bit hesitant,” she says. “I can appreciate President Trump trying to get this moving fast and I’ve...
Source: TIME: Health - January 5, 2021 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 Source Type: news
Boston Doctor Develops Severe Allergic Reaction After Getting Moderna Vaccine
The patient, who has a severe shellfish allergy, recovered quickly with treatment. Until now, reports of severe reactions had been linked to the Pfizer vaccine.
Source: NYT Health - December 25, 2020 Category: Consumer Health News Authors: Katherine J. Wu Tags: Vaccination and Immunization Drugs (Pharmaceuticals) Anaphylactic Shock Coronavirus (2019-nCoV) Immune System Allergies Centers for Disease Control and Prevention Moderna Inc Pfizer Inc your-feed-healthcare Source Type: news
Successful vaccination with tetanus and diphtheria and acelluar pertussis vaccine after adverse reaction to diphtheria and tetanus toxoids and acellular pertussis vaccine or diphtheria and tetanus vaccine in pediatric patients
Diphtheria, tetanus, and pertussis vaccination is an integral component of the pediatric immunization schedule, with diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine administered to patients as a primary series at 2, 4, and 6 months of age and booster doses at 15 to 18 months and 4 to 6 years of age. A single tetanus and diphtheria and acelluar pertussis (Tdap) vaccine dose is recommended at 11 to 12 years old. Per the Centers for Disease Control and Prevention, contraindications to DTaP and Tdap vaccination include anaphylaxis after a previous dose or to a vaccine component and encephalopathy within 7...
Source: Annals of Allergy, Asthma and Immunology - June 18, 2019 Category: Allergy & Immunology Authors: Neha Sirohi Campbell, Denise Diprimio Kalman Tags: Letter Source Type: research
The Florence Statement on Triclosan and Triclocarban
Author Affiliations open
1Biodesign Center for Environmental Security, Arizona State University, Tempe, Arizona, USA
2Green Science Policy Institute, Berkeley, California, USA
3Department of Epidemiology, UNC Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA
4Environmental Working Group, Washington, District of Columbia, USA
5Department of Civil, Environmental, and Geo-Engineering, University of Minnesota, Minneapolis, Minnesota, USA
6Medical University of South Carolina, Department of Public Health Sciences, Charleston, South Carolina, USA
7Health Research Communicati...
Source: EHP Research - June 20, 2017 Category: Environmental Health Authors: Daniil Lyalko Tags: Brief Communication Source Type: research
School Board Member Resigns After Saying 'Just Shoot' Kids With Food Allergies
A school board official in Michigan made a public remark about shooting kids with food allergies -- and it caused her to leave her job. Advocates say it also demonstrates there's still a lack of knowledge and tolerance of the serious medical condition, even among those who work with children.
On Tuesday, suburban Detroit's Clawson Public Schools announced that Board of Education Trustee Linda Grossmann had resigned after making the comment at a school board meeting during a discussion about how children with food allergies have changed what food can be distributed at schools.
"Well, you should just shoot them," Grossman...
Source: Healthy Living - The Huffington Post - November 26, 2014 Category: Consumer Health News Source Type: news
'More likely to be murdered' than die from food allergies
The CDC estimates that around 4-6% of children in the US suffer from food allergies. Severe food allergies can lead to anaphylaxis - a reaction that causes swelling and breathing difficulties. Although a serious condition, a new study suggests that a person is more likely to be murdered than die from a food allergy.Food allergies are increasingly becoming a safety and public health concern worldwide. The Centers for Disease Control and Prevention (CDC) notes that prevalence of food allergies increased 18% between 1997 and 2007.
Source: Health News from Medical News Today - December 1, 2013 Category: Consumer Health News Tags: Allergy Source Type: news
Establishing the safety of influenza vaccine in egg-allergic individuals.
This article will trace the evolution of this practice.
PMID: 23805959 [PubMed - in process]
Source: Pediatric Annals - July 1, 2013 Category: Pediatrics Authors: Greenhawt MJ Tags: Pediatr Ann Source Type: research
